{"id":38335,"date":"2023-05-17T13:11:25","date_gmt":"2023-05-17T11:11:25","guid":{"rendered":"https:\/\/kapitalpartner.dk\/?p=38335"},"modified":"2023-05-17T13:11:26","modified_gmt":"2023-05-17T11:11:26","slug":"after-positive-study-pain-patch-is-now-also-approved-in-israel","status":"publish","type":"post","link":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/","title":{"rendered":"After positive study, Pain Patch is now also approved in Israel"},"content":{"rendered":"\n<p><strong>After CS Medica recently obtained positive results from a clinical study with its CBD pain patch, CS Medica has now also received approval in Israel for sale in the retail market (OTC). It is expected that CS Medica&#8217;s other CBD-based products will also be approved in Israel, so that the entire product range can be sold in Israel.<\/strong><\/p>\n\n\n\n<p><em>CS Medica: Ticker: CSMED | Price: DKK 6.44 | Market Cap: DKK 84 million | YTD price development: -42%.<\/em><\/p>\n\n\n\n<p><strong>CS Medica<\/strong> is a Danish MedTech\/biotech company focusing on, among other things, the treatment of pain, stress and autoimmune diseases with CBD (non-euphoriant substance from the cannabis plant) as a primary ingredient. The products are sold under the brand name CANNASEN to e.g. pharmacies and retail chains such as Matas, and as OEM to pharmaceutical companies and manufacturers. Several of CS Medica&#8217;s products are probably the only CBD products registered as &#8220;medical devise&#8221; under the European MDD directive, which gives the company a first mover advantage in CBD-based products.<\/p>\n\n\n\n<p><strong>Long-term share price effect<\/strong><\/p>\n\n\n\n<p>Pain Patch is one of CS Medica&#8217;s CBD-based products, all of which are sold at retail (OTC). The approval in Israel opens up a market that is among the leading countries in terms of sales of cannabis-based products, including CBD. CS Medica has not disclosed when the rest of its product range will be approved in Israel, which could make a significant contribution to the company&#8217;s revenue.<\/p>\n\n\n\n<p>The price impact of the news is probably modest in itself, but the approval strengthens the investment case for sales in more and more countries and thus the long-term share price.<\/p>\n\n\n\n<p>In the short term, the share price is still primarily linked to news about CS Medica&#8217;s Chinese activities, including the joint venture and potential investment from China&#8217;s RongShi, which over the past 12 months has resulted in very large price fluctuations.<\/p>\n\n\n\n<p><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">Read more<\/mark><\/strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">:<\/mark> <strong>The investment case and price triggers for CS Medica<\/strong><\/p>\n\n\n\n<p><strong>Price development for CS Medica A\/S vs. Kapital Partner Healthcare Index the past year<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1045\" height=\"400\" src=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/05\/image-34.png\" alt=\"\" class=\"wp-image-38336\" srcset=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/05\/image-34.png 1045w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/05\/image-34-300x115.png 300w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/05\/image-34-768x294.png 768w\" sizes=\"(max-width: 1045px) 100vw, 1045px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>After CS Medica recently obtained positive results from a clinical study with its CBD pain patch, CS Medica has now also received approval in Israel for sale in the retail market (OTC). It is expected that CS Medica&#8217;s other CBD-based products will also be approved in Israel, so that the entire product range can be [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":37661,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[29],"tags":[],"class_list":["post-38335","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investeringscases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>After positive study, Pain Patch is now also approved in Israel | Kapital Partner A\/S<\/title>\n<meta name=\"description\" content=\"Healthscare selskabet CS Medica f\u00e5r CBD baserede pain patch godkent i Israel\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"After positive study, Pain Patch is now also approved in Israel | Kapital Partner A\/S\" \/>\n<meta property=\"og:description\" content=\"Healthscare selskabet CS Medica f\u00e5r CBD baserede pain patch godkent i Israel\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\" \/>\n<meta property=\"og:site_name\" content=\"Kapital Partner A\/S\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/kapitalpartner\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-17T11:11:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-17T11:11:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"791\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anders S\u00f8ndergaard\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KapitalPartner\" \/>\n<meta name=\"twitter:site\" content=\"@KapitalPartner\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders S\u00f8ndergaard\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\"},\"author\":{\"name\":\"Anders S\u00f8ndergaard\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed\"},\"headline\":\"After positive study, Pain Patch is now also approved in Israel\",\"datePublished\":\"2023-05-17T11:11:25+00:00\",\"dateModified\":\"2023-05-17T11:11:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\"},\"wordCount\":348,\"publisher\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg\",\"articleSection\":[\"Investeringscases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\",\"url\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\",\"name\":\"After positive study, Pain Patch is now also approved in Israel | Kapital Partner A\/S\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg\",\"datePublished\":\"2023-05-17T11:11:25+00:00\",\"dateModified\":\"2023-05-17T11:11:26+00:00\",\"description\":\"Healthscare selskabet CS Medica f\u00e5r CBD baserede pain patch godkent i Israel\",\"breadcrumb\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage\",\"url\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg\",\"contentUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg\",\"width\":791,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kapitalpartner.dk\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investeringscases\",\"item\":\"https:\/\/kapitalpartner.dk\/category\/investeringscases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"After positive study, Pain Patch is now also approved in Israel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kapitalpartner.dk\/#website\",\"url\":\"https:\/\/kapitalpartner.dk\/\",\"name\":\"Kapital Partner A\/S\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kapitalpartner.dk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\",\"name\":\"Kapital Partner A\/S\",\"url\":\"https:\/\/kapitalpartner.dk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png\",\"contentUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png\",\"width\":496,\"height\":432,\"caption\":\"Kapital Partner A\/S\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/kapitalpartner\",\"https:\/\/x.com\/KapitalPartner\",\"https:\/\/www.linkedin.com\/company\/10438322\",\"https:\/\/www.youtube.com\/channel\/UCODuY5PE_fxmp2nSSsq3l3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed\",\"name\":\"Anders S\u00f8ndergaard\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g\",\"caption\":\"Anders S\u00f8ndergaard\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"After positive study, Pain Patch is now also approved in Israel | Kapital Partner A\/S","description":"Healthscare selskabet CS Medica f\u00e5r CBD baserede pain patch godkent i Israel","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/","og_locale":"en_US","og_type":"article","og_title":"After positive study, Pain Patch is now also approved in Israel | Kapital Partner A\/S","og_description":"Healthscare selskabet CS Medica f\u00e5r CBD baserede pain patch godkent i Israel","og_url":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/","og_site_name":"Kapital Partner A\/S","article_publisher":"https:\/\/www.facebook.com\/kapitalpartner","article_published_time":"2023-05-17T11:11:25+00:00","article_modified_time":"2023-05-17T11:11:26+00:00","og_image":[{"width":791,"height":800,"url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg","type":"image\/jpeg"}],"author":"Anders S\u00f8ndergaard","twitter_card":"summary_large_image","twitter_creator":"@KapitalPartner","twitter_site":"@KapitalPartner","twitter_misc":{"Written by":"Anders S\u00f8ndergaard","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#article","isPartOf":{"@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/"},"author":{"name":"Anders S\u00f8ndergaard","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed"},"headline":"After positive study, Pain Patch is now also approved in Israel","datePublished":"2023-05-17T11:11:25+00:00","dateModified":"2023-05-17T11:11:26+00:00","mainEntityOfPage":{"@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/"},"wordCount":348,"publisher":{"@id":"https:\/\/kapitalpartner.dk\/#organization"},"image":{"@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage"},"thumbnailUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg","articleSection":["Investeringscases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/","url":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/","name":"After positive study, Pain Patch is now also approved in Israel | Kapital Partner A\/S","isPartOf":{"@id":"https:\/\/kapitalpartner.dk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage"},"image":{"@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage"},"thumbnailUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg","datePublished":"2023-05-17T11:11:25+00:00","dateModified":"2023-05-17T11:11:26+00:00","description":"Healthscare selskabet CS Medica f\u00e5r CBD baserede pain patch godkent i Israel","breadcrumb":{"@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#primaryimage","url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg","contentUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2023\/04\/CSM-pain.jpg","width":791,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/kapitalpartner.dk\/en\/after-positive-study-pain-patch-is-now-also-approved-in-israel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kapitalpartner.dk\/en\/"},{"@type":"ListItem","position":2,"name":"Investeringscases","item":"https:\/\/kapitalpartner.dk\/category\/investeringscases\/"},{"@type":"ListItem","position":3,"name":"After positive study, Pain Patch is now also approved in Israel"}]},{"@type":"WebSite","@id":"https:\/\/kapitalpartner.dk\/#website","url":"https:\/\/kapitalpartner.dk\/","name":"Kapital Partner A\/S","description":"","publisher":{"@id":"https:\/\/kapitalpartner.dk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kapitalpartner.dk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kapitalpartner.dk\/#organization","name":"Kapital Partner A\/S","url":"https:\/\/kapitalpartner.dk\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/","url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png","contentUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png","width":496,"height":432,"caption":"Kapital Partner A\/S"},"image":{"@id":"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/kapitalpartner","https:\/\/x.com\/KapitalPartner","https:\/\/www.linkedin.com\/company\/10438322","https:\/\/www.youtube.com\/channel\/UCODuY5PE_fxmp2nSSsq3l3w"]},{"@type":"Person","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed","name":"Anders S\u00f8ndergaard","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g","caption":"Anders S\u00f8ndergaard"}}]}},"_links":{"self":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/38335"}],"collection":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/comments?post=38335"}],"version-history":[{"count":1,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/38335\/revisions"}],"predecessor-version":[{"id":38339,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/38335\/revisions\/38339"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/media\/37661"}],"wp:attachment":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/media?parent=38335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/categories?post=38335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/tags?post=38335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}